Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

25%

1 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
1(33.3%)
Phase 2
1(33.3%)
Phase 3
1(33.3%)
3Total
N/A(1)
Phase 2(1)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07534501Not ApplicableNot Yet Recruiting

'Eat Well' Produce Prescription Randomized Controlled Trial

Role: collaborator

NCT06790069Completed

Evaluating the Impact of a Symptom Checker on Healthcare-seeking Decisions: a Mixed-Methods Study

Role: collaborator

NCT00198718Phase 2Completed

Single-dose Postpartum Vitamin A Supplementation of Mothers and Neonates

Role: collaborator

NCT00330304Phase 3Completed

Isoniazid Prophylaxis With Concomitant Cotrimoxazole in HIV-infected Children

Role: collaborator

All 4 trials loaded